Wendy Guy - 05 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Reporting relationship: Chief Administrative Officer
Issuer ticker: PCSA
Reported as of: 05 Aug 2022
Net transaction value: -$5,649
SEC form: 4
Accepted by SEC: 09 Aug 2022, 16:23:55 UTC
Prior SEC filing: 05 Jul 2022
Next SEC filing: 03 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Wendy Guy by Michael B. Kirwan, as Attorney-in-Fact

Key filing fact

Wendy Guy filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 09 Aug 2022.

Key facts

This page summarizes Wendy Guy's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 09 Aug 2022, 16:23.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

PCSA transaction

Options Exercise

PCSA transaction

Tax liability

PCSA holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Vesting of time-based restricted shares.